![]() |
市场调查报告书
商品编码
1352091
全球生物相容性涂料市场评估:按类型、等级、材料、最终用户、地区、机会、预测(2016-2030)Biocompatible Coatings Market Assessment, By Type, By Grade, By Materials, By End-user, By Region, Opportunities and Forecast, 2016-2030F |
全球生物相容性涂料市场规模预计将从2022年的154亿美元增加到2030年的412亿美元,2023-2030年预测期间复合年增长率为13.1%。生物相容性涂料专注于医疗器材领域所需涂料技术的开发,预计该领域将在未来几年取得重大发展。
市面上已有的产品对于医疗级应用的血液相容性不足。血液相容性涂层解决方案在抑制医疗设备上的血液凝固方面在医疗领域获得了巨大的关注。
随着城市化的快速发展,对卫生产品的需求不断增加,推动了消费品和家居产品中生物相容性涂料的市场需求。确保病患安全和产品品质的严格法规和政府要求正在推动生物相容性涂层的引入。政府机构的法规迫使医疗器材製造商在产品获得批准和商业化之前遵守严格的指导方针并提供生物相容性保证。医疗相关感染 (HAI) 会使患者病情加重,导致医疗费用增加、长期心理创伤和更严重的后果。世界各地的政府机构,例如 EMA 和 FDA,优先考虑治疗的安全性,并制定了具体的法规,以确保製造的医疗器材符合生物相容性标准。抗菌涂层在对抗病原体和减少传染病的传播方面非常有效。
对病人安全的日益担忧迫使政府机构在开发医疗级组件时采取严格的指导方针。将生物相容性标准应用于此类设备使公司能够创建创新的解决方案来满足法规要求。因此,政府监管透过鼓励更多医疗保健公司竞争创造有效的解决方案并推动创新来实现所规定的条件,释放了巨大的市场潜力。
COVID-19大流行导致全球口罩和医疗产品严重短缺,严重扰乱全球供应链。医疗设备对于积极救治患者至关重要,整个医院都高度关注。生物相容性涂层的引入透过利用该技术来製造更多的医疗器材和设备,彻底改变了医疗应用。使用相关材料的生物相容性涂层市场爆炸性成长,为获得各个医疗领域的经验创造了绝佳的机会。疫情期间,随着对生物相容性医疗器材的需求增加,医疗产业蓬勃发展。这使得生物相容性涂料产业获得最大程度的收入。
俄罗斯吞併乌克兰引发了全球健康危机,导致大量人员死亡、流离失所以及缺乏资金来支持受战争影响的人们。儘管情况困难,但来自邻国和已开发国家的医疗设备和药品等援助对乌克兰来说却变得极为重要。满足需求的需求增加了生物相容性医疗器材和食品包装产品的产量,最终导致了全球生物相容性涂料市场。包括生物相容性涂料在内的各个医疗领域的市场机会正在显着成长。
本报告研究分析了全球生物相容性涂料市场,提供市场规模和预测、市场动态、主要参与者的现状和前景等。
Global biocompatible coatings market size was valued at USD 15.4 billion in 2022, which is expected to reach USD 41.2 billion in 2030, with a CAGR of 13.1% for the forecast period between 2023 and 2030. Biocompatible coating emphasizes developing coating technologies, which are required in the medical devices sector which is expected to incur major development in the coming years. With the concern of patient safety biocompatible coatings become crucial in enhancing the functionality and biocompatibility of medical devices, implants, and prominent equipment.
Biocompatible coatings are used for imparting antimicrobial activities using development of cementless hydroxyapatite (HA)-coated titanium orthopedic prostheses. Hemocompatible coatings are significantly related to thrombogenic and thromboembolic complications where the coating is applied on medical-grade materials. Hemocompatible coatings comprises of active and passive types which have their specific characteristics. Ceramic oxide coatings for biomedical purposes are extensively used for damaged bone tissue and joint replacement. Aumina and zirconia are suitable ceramic materials used, because of their unique characteristics such as excellent wear resistance and biocompatibility. The progressive drivers for biocompatible coatings materials carry enormous potential for global market and create massive opportunities to expand in different segmentation.
Hemocompatible has high tolerance with blood, which is associated to thrombogenic and thromboembolic complications induced by biomaterial surfaces. Commercial products in the market products possess inadequate hemocompatibility for application in the medical grade. Hemocompatible coating solutions are tremendously driving the medical sector in inhibiting blood coagulation on the medical device. Health-driven companies are significantly producing such effective devices using biocompatible coatings, creating huge market opportunities as the technology requires prominent usage of materials.
Surmodics's proprietary PhotoLink UV curing technology can successfully develop coatings for all medical-grade materials using light-activated chemistry that generate bonds rapidly. Their exceptional coating solutions can easily integrate into existing manufacturing systems and enhance medical device functioning. Active (heparin) and passive (non-heparin) hemocompatible coatings inhibit thrombin generation and reduce protein adsorption. The significance of biocompatible coatings can be explored in different medical devices which will open global market opportunities by introducing more innovations for such coatings.
Rapid urbanization along with demand for hygienic products has raised concerns which is driving the market demand for biocompatible coatings in consumer and household products. Stringent regulations and government conditions on ensuring patient safety and product quality encourages to implement biocompatible coatings. Regulations by government entities have bounded medical device manufacturers to adhere stringent guidelines and provide assurance about biocompatibility before products can be approved and commercialized. Healthcare-associated infections (HAIs) can exacerbate the patient's conditions, increasing healthcare costs, prolonged mental trauma, and more severe outcomes. Global government agencies like European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA) have created specific regulations that prioritize safety in treatments and ensure manufactured medical devices should meet the biocompatibility standards. Antibacterial coatings are highly effective in combating pathogens and restricting the transmission of infections.
The rising concerns for patient safety is forcing government agencies to incorporate stringent guidelines for developing medical grade components. Applying biocompatibility standards on such devices encourages companies to generate innovative solutions to meet the regulations. Consequently, government regulations can also create huge market potential as more medical companies compete to generate effective solutions and drive innovation in achieving the imposed conditions.
The COVID-19 pandemic severely led to shortage of masks and healthcare products across the globe and global supply chain was prominently disrupted. The indispensable need for medical devices was serious concerns across the hospitals to provide active patient treatment. Incorporation of biocompatible coatings significantly revolutionized medical applications by utilizing the technology in building more medical devices and equipment. The market for biocompatible coating using relevant materials exploded and generated excellent opportunities to gain experience in various medical segmentation. The pandemic time was a boom for medical industries by increasing requirement of biocompatible medical devices which has created immense potential for building devices that biocompatible norms must regulate. This has taken the biocompatible coating industry to the utmost level of revenue generation.
The annexation of Russia on Ukraine has sparked global health crises which led to enormous decease, displacement of people, and lack in sufficient funds to support people affected from the war. Despite the prevailing difficulties, aid from other neighboring and developed countries such as medical devices, useful medicines, etc. has significantly became crucial for Ukraine. The demand to fulfill the needs has increased the production of biocompatible medical devices and food packaged products which ultimately derived the biocompatible coatings market across the globe. The market opportunities have grown prominently in various health care sectors including biocompatible coatings.
The advancement in biocompatible coating technologies has prominently gained interest to incorporate in various medical applications such as device-based therapies, blood-contacted equipment, etc. Evonik has successfully commenced proprietary surface modification technology called Endexo, which is based on low molecular weight fluoro-oligomers which significantly assist in enhancing the biocompatibility of medical devices making direct contact with blood, tissue, and other body fluids. It possesses surface modifying characteristics that impart permanent and durable modification of surface properties without altering or impacting the device dimensions or its functionality. Surface modification using Endexo biocompatible coating technology can effectively reduce around 99% platelet adhesion and thrombus formation from blood contacting-devices such as vascular stents, catheters, etc. The importance of biocompatible coating technologies in medical applications can be recognized which has immense potential for global market to grow non-linearly.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work